Urgent.News

What's breaking now, across hundreds of outlets.

World

BUSINESS REFLECTION: Crossed Wires: GLP-1s — the tangled world of weight loss, stigma, addiction and money

GLP-1 drugs promise transformative weight-loss and broader health benefits, but stigma, regaining of weight, high costs and insurers’ short-term thinking complicate their use.

BUSINESS REFLECTION: Crossed Wires: GLP-1s — the tangled world of weight loss, stigma, addiction and money

GLP-1 drugs offer transformative weight-loss and health benefits, but their use is complicated by stigma, regaining weight, high costs, and insurers' short-term thinking. The drugs, originally developed for diabetes treatment, were approved for weight loss in 2014 and 2021. While the drugs are not physically addictive, they can have a psychological addictive component, leading to rapid weight regain after stopping treatment.

GLP-1s dampen addictive behaviors and the urge to eat, but users often regain weight within a year, making them an ongoing treatment rather than a cure. Side effects are mostly digestive and temporary, with no significant long-term harm for most users. However, these drugs remain expensive, with monthly costs ranging from $150 to $199, making them inaccessible for many, particularly outside wealthy countries.

Insurers, driven by short-term thinking, have not yet started covering these "miracle" weight-loss drugs, leaving patients to bear the financial burden.

Rewritten by urgent.news; may contain errors — check the original.

Source: dailymaverick.co.za

Read the original at dailymaverick.co.za →

Report a problem with this story

More in World

More from Sunday 22 November →